Evidence map›Paper›PMID 35647329›Full record

ArticleeNeurologicalSci2022

Seronegative neuromyelitis optica spectrum disorder in primary familial brain calcification with

Masahiro Biyajima, Yuya Kobayashi, Kiyoshi Nakafuji, Rie Watanabe, Koichi Tazawa, Wataru Ishii, Shunichi Satoh, Kenichi Hoshi, Hisaka Kurita, Isao Hozumi and 1 more

Erratum issuedOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in eNeurologicalSci, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. The Genetics of Primary Familial Brain Calcification: A Literature Review.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Masahiro BiyajimaDepartment of Neurology, Nagano Red Cross Hospital, Nagano, Japan.
Yuya KobayashiDepartment of Neurology, Nagano Red Cross Hospital, Nagano, Japan.
Kiyoshi NakafujiDepartment of Neurology, Nagano Red Cross Hospital, Nagano, Japan.
Rie WatanabeDepartment of Neurology, Nagano Red Cross Hospital, Nagano, Japan.
Koichi TazawaDepartment of Neurology, Nagano Red Cross Hospital, Nagano, Japan.
Wataru IshiiDepartment of Neurology, Nagano Red Cross Hospital, Nagano, Japan.
Shunichi SatohDepartment of Neurology, Nagano Red Cross Hospital, Nagano, Japan.
Kenichi HoshiDepartment of Neurology, Nagano Red Cross Hospital, Nagano, Japan.
Hisaka KuritaLaboratory of Medical Therapeutics and Molecular Therapeutics, Gifu Pharmaceutical University, Gifu, Japan.
Isao HozumiLaboratory of Medical Therapeutics and Molecular Therapeutics, Gifu Pharmaceutical University, Gifu, Japan.
Hiroyuki YahikozawaDepartment of Neurology, Nagano Red Cross Hospital, Nagano, Japan.
Nagano Red Cross Hospital · JPGifu Pharmaceutical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

•This case indicates that the

Indexed as

Blood-brain barrierFahr diseaseNeuromyelitis optica spectrum disorderPlatelet-derived growth factor subunit B (PDGFB)Primary familial brain calcification

Identifiers

PMID35647329
PMCPMC9133546
OpenAlexW4281396508

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.